Docosahexaenoic acid-containing phosphatidylcholine affects the binding of monoclonal antibodies to purified Kb reconstituted into liposomes

Biochimica et Biophysica Acta - Biomembranes

Volumn 1467, Issue 2, 2000, Pages 293-306

  Jenski, Laura J ^a   Nanda, Paul K ^a   Jiricko, Philip ^a   Stillwell, William ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Docosahexaenoic acid; Liposome; Major histocompatibility complex class I antigen; Omega 3 fatty acid

Indexed keywords

ARACHIDONIC ACID; BETA 2 MICROGLOBULIN; DOCOSAHEXAENOIC ACID; EPITOPE; LINOLEIC ACID; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; OLEIC ACID; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; STEARIC ACID; T LYMPHOCYTE RECEPTOR;

ALPHA CHAIN; ANIMAL CELL; ANTIBODY STRUCTURE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CONFORMATION; CONFORMATIONAL TRANSITION; LIPID COMPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; BETA 2-MICROGLOBULIN; CELL LINE; DOCOSAHEXAENOIC ACIDS; EPITOPES; H-2 ANTIGENS; HUMANS; LIPOSOMES; MEMBRANE LIPIDS; MICE; PHOSPHATIDYLCHOLINES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEOLIPIDS; T-LYMPHOCYTES;

EID: 0034714362     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(00)00227-3     Document Type: Article

References (46)

1. Garboczi D.N., Biddison W.E. Shapes of MHC restriction. Immunity. 10:1999;1-7.
2. Rohren E.M., McCormick D.J., Pease L.R. Peptide-induced conformational changes in class I molecules. Direct detection by flow cytometry. J. Immunol. 152:1994;5337-5343.
3. Celia H., Wilson-Kubalek E., Milligan R.A., Teyton L. Structure and function of a membrane-bound murine MHC class I molecule. Proc. Natl. Acad. Sci. USA. 96:1999;5634-5639.
4. Edidin M., Kuo S.C., Sheetz M.P. Lateral movements of membrane glycoproteins restricted by dynamic cytoplasmic barriers. Science. 254:1991;1379-1382.
5. Damjanovich S., Vereb G., Schaper A., Jenei A., Matko J., Starink J.P.P., Fox G.Q., Arndt-Jovin D.J., Jovin T.M. Structural hierarchy in the clustering of HLA class I molecules in the plasma membrane of human lymphoblastoid cells. Proc. Natl. Acad. Sci. USA. 92:1995;1122-1126.
6. Hwang J., Gheber L.A., Margolis L., Edidin M. Domains in cell plasma membranes investigated by near-field scanning optical microscopy. Biophys. J. 74:1998;2184-2190.
7. Matko J., Bushkin Y., Wei T., Edidin M. Clustering of class I HLA molecules on the surfaces of activated and transformed human cells. J. Immunol. 152:1994;3353-3360.
8. Capps G.G., Robinson B.E., Lewis K.D., Zuniga M.C. In vivo dimeric association of class I MHC heavy chains. J. Immunol. 151:1993;159-169.
9. Chakrabarti A., Matko J., Rahman N.A., Barisas B.G., Edidin M. Self-association of class I major histocompatibility complex molecules in liposome and cell surface membranes. Biochemistry. 31:1992;7182-7189.
10. Little A.M., Nossner E., Parham P. Dissociation of β2-m from HLA class I heavy chains correlates with acquisition of epitopes in the cytoplasmic tail. J. Immunol. 154:1995;5205-5215.
11. Gibson N.J., Brown M.F. Lipid headgroup and acyl chain composition modulate the MI-MII equilibrium of rhodopsin in recombinant membranes. Biochemistry. 32:1993;2438-2454.
12. Brown M.F. Modulation of rhodopsin function by properties of the membrane bilayer. Chem. Phys. Lipids. 73:1994;159-180.
13. Hunter G.W., Bigelow D.J., Squier T.C. Lysophosphatidylcholine modulates catalytically important motions of the Ca-ATPase phosphorylation domain. Biochemistry. 38:1999;4604-4612.
14. Vallette G., Vranckx R., Martin M.E., Benassayag C., Nunez E.A. Conformational changes in rodent and human alpha-fetoprotein: influence of fatty acids. Biochim. Biophys. Acta. 997:1989;302-312.
15. Bene L., Szollosi J., Balazs M., Matyus L., Gaspar R., Ameloot M., Dale R.E., Damjanovich S. Major histocompatibility complex class I protein conformation altered by transmembrane potential changes. Cytometry. 27:1997;353-357.
16. Muller C.P., Stephany D.A., Shinitzky M., Wunderlich J.R. Changes in cell-surface expression of MHC and Thy1.2 determinants following treatment with lipid modulating agents. J. Immunol. 131:1983;1356-1362.
17. Bodnar A., Jenei A., Bene L., Damjanovich S., Matko J. Modification of membrane cholesterol level affects expression and clustering of class I HLA molecules at the surface of JY human lymphoblasts. Immunol. Lett. 54:1996;221-226.
18. Pascale A.W., Ehringer W.D., Stillwell W., Sturdevant L.K., Jenski L.J. Omega-3 fatty acid modification of membrane structure and function. II. Alteration by docosahexaenoic acid of tumor cell sensitivity to immune cytolysis. Nutr. Cancer. 19:1993;147-158.
19. Ehringer W., Belcher D., Wassall S., Stillwell W. A comparison of the effects of linolenic (18Ω3) and docosahexaenoic (22:6Ω3) acids on phospholipid bilayers. Chem. Phys. Lipids. 54:(3):1990;79-88.
20. Stillwell W., Ehringer W., Jenski L.J. Docosahexaenoic acid increases permeability of lipid vesicles and tumor cells. Lipids. 28:1993;103-108.
21. Dumaual A.C., Jenski L.J., Stillwell W. Liquid crystalline/gel state phase separation in docosahexaenoic acid-containing bilayers and monolayers. Biochim. Biophys. Acta. 1463:2000;395-406.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
23. Rigaud J.L., Pitard B., Levy D. Reconstitution of membrane protein insertion into liposomes: application to energy transducing membrane proteins. Biochim. Biophys. Acta. 1234:1995;223-246.
24. k in liposomes formed by detergent dialysis. Biochemistry. 23:1984;4401-4409.
25. Stallcup K.C., Springer T.A., Mescher M.F. Characterization of an anti-H-2 monoclonal antibody and its use in large-scale antigen purification. J. Immunol. 127:1981;923-930.
26. T.A. Springer, Cell-surface differentiation in the mouse. Characterization of 'jumping' and 'lineage' antigens using xenogeneic rat monoclonal antibodies, in: R.H. Kennett, T.J. McKearn, K.B. Bechtol (Eds.), Monoclonal Antibodies, Plenum Press, New York, 1980, pp. 185-217.
27. d antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J. Immunol. 125:1980;2473-2477.
28. b haplotype reveal genetic control of isotype expression. J. Immunol. 126:1981;317-321.
29. Allen H., Wraith D., Pala P., Askonas B., Flavell R.A. Domain interactions of H-2 class I antigens alter cytotoxic T-cell recognition sites. Nature. 309:1984;279-281.
30. Glazer A.N. Light guides. Directional energy transfer in a photosynthetic antenna. J. Biol. Chem. 264:1989;1-4.
31. Killian J.A. Hydrophobic mismatch between proteins and lipids in membranes. Biochim. Biophys. Acta. 1376:1998;401-416.
32. b heavy chains. Mol. Immunol. 27:1990;169-180.
33. Shields M.J., Moffat L.E., Ribaudo R.K. Functional comparison of bovine, murine, and human beta2-microglobulin: interactions with murine MHC I molecules. Mol. Immunol. 35:1998;919-928.
34. Williams E.E., May B.D., Stillwell W., Jenski L.J. Docosahexaenoic acid (DHA) alters the phospholipid molecular species composition of membranous vesicles exfoliated from the surface of a murine leukemia cell line. Biochim. Biophys. Acta. 1418:1999;185-196.
35. N.J. Salem, H.-Y. Kim, J.A. Yergey, Docosahexaenoic acid: membrane function and metabolism, in: A.P. Simopoulos, R.R. Kifer, R.E. Martin (Eds.), Health Effects of Polyunsaturated Fatty Acids in Seafoods, Academic Press, New York, 1986, pp. 319-351.
36. Goppelt-Strube M., Resch K. Polyunsaturated fatty acids are enriched in the plasma membranes of mitogen-stimulated T-lymphocytes. Biochim. Biophys. Acta. 904:1987;22-28.
37. Zerouga M., Stillwell W., Stone J., Powner A., Jenski L.J. Phospholipid class as a determinant in docosahexaenoic acid's effect on tumor cell viability. Anticancer Res. 16:1996;2863-2868.
38. Feng C., Keisler D.H., Fritsche K.L. Dietary omega-3 polyunsaturated fatty acids reduce IFN-γ receptor expression in mice. J. Interferon Cytokine Res. 19:1999;41-48.
39. Sasaki T., Kanke Y., Kudoh K., Misawa Y., Shimizu J., Takita T. Effects of dietary docosahexaenoic acid on surface molecules involved in T cell proliferation. Biochim. Biophys. Acta. 1436:1999;519-530.
40. Chen W., Fecondo J., McCluskey J. The structural influence of individual residues located within peptide antigen depends upon their sequence context. Mol. Immunol. 31:1994;1069-1075.
41. Kuhns S.T., Pease L.R. A region of conformational variability outside the peptide-binding site of a class I MHC molecule. J. Immunol. 161:1998;6745-6750.
42. 2-microglobulin regulation of cell surface MHC class I conformation and expression. J. Immunol. 148:1992;3723-3732.
43. Roof R.W., Luescher I.F., Unanue E.R. Phospholipids enhance the binding of peptides to class II major histocompatibility molecules. Proc. Natl. Acad. Sci. USA. 87:1990;1735-1739.
44. Schlager S.I., Ohanian S.H. Role of membrane lipids in the immunological killing of tumor cells: I. Target cell lipids. Lipids. 18:1983;475-482.
45. Claesson M.H., Nisse M.H. Binding of human β2-microglobulin to murine EL4 thymoma cells upregulates MHC class I heavy-chain epitopes, inhibits IL-2 secretion and induces resistance to killing by natural killer cells. Immunol. Lett. 39:1994;195-202.
46. Davis D.M., Mandelboim O., Luque I., baba E., Boyson J., Strominger J.L. The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells. J. Exp. Med. 189:1999;1265-1274.